ACTIVE SUBSTANCE / INN

AFLIBERCEPT

Brand name(s): Vgenfli, Opuviz, Ahzantive, EYLEA HD, Afiveg, Mynzepli, Pavblu, Skojoy, Eydenzelt, EYLEA, Eyluxvi, Baiama, Zaltrap, Eylea, Eiyzey, Afqlir, Yesafili
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
AUTHORISED
Wet Macular Degeneration;Macular Edema;Retinal Vein Occlusio…
Colorectal Neoplasms
ACTIVE SUBSTANCE
Aflibercept
REGULATORS
FDA · EMA
SPONSORS / MAH
Celltrion Healthcare Hungary Kft., Formycon AG, Advanz Pharma Limited
TOTAL APPLICATIONS
17
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
EYLEABLA125387REGENERON PHARMACEUTICALSPrescription
EYLEA HDBLA761355REGENERON PHARMACEUTICALSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EyleaBayer AGAuthorised21/11/2012Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlu…
AfqlirSandoz GmbHAuthorised13/11/2024Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlu…
YesafiliBiosimilar Collaborations Ireland LimitedAuthorised15/09/2023Macular Edema;Retinal Vein Occlusion;Diabetic Retinopathy;Myopia, Degenerative;D…
OpuvizSamsung Bioepis NL B.V.Authorised13/11/2024Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlu…
EydenzeltCelltrion Healthcare Hungary Kft.Authorised12/02/2025Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlu…
EiyzeyZaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.Authorised14/08/2025Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlu…
AfivegSTADA Arzneimittel AGAuthorised18/08/2025Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlu…
EyluxviBiolitec pharma Limited Zweigniederlassung JenaAuthorised15/09/2025Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlu…
BaiamaFormycon AGAuthorised13/01/2025Wet Macular Degeneration;Macular Edema;Retinal Vein Occlusion;Choroidal Neovascu…
AhzantiveFormycon AGAuthorised13/01/2025Wet Macular Degeneration;Macular Edema;Retinal Vein Occlusion;Choroidal Neovascu…

FULL INTELLIGENCE ON AFLIBERCEPT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →